Resource
UK Tax Strategy 2019
PRA Health Sciences, Inc. ("PRA") and its subsidiaries have published this UK Tax Strategy (the "Strategy") to document those parts of PRA's tax…
All Insights
Resource
Blog
Putting the “Patient Perspective” in Pediatric Patient Engagement
During PRA Health Sciences’ celebration of UNICEF’s World’s Children Day on November 20, experts from LSU-Shreveport, UNICEF, the Center for…
Blog
Ensuring Children’s Voices are Heard in Clinical Trials
World Children’s Day at PRA Health Sciences recognizes children’s rights to safe and effective treatments. This year, the teams from PRA’s Center for…
Capability
Lab Presentation List
A list of 2019 presentations from the labs team.
Blog
Janssen Pharmaceuticals and PRA Health Sciences Launch First Fully Virtual Trial for Heart Failure Drug Approval
Janssen Pharmaceuticals and PRA Health Launch First Fully Virtual Trial for Heart Failure Drug Approval. Healthcare giant Janssen Pharmaceuticals and…
Blog
Master Protocols in Clinical Trials
Master protocols are a powerful but under-utilized option for complex clinical development programs. Our Greg Licholai, MD, explores:
Blog
Lighting the Night to Fight Cancer
Every year, more than 60,000 people are diagnosed with leukemia, and more than 382,000 live with the disease or are in remission.
Fact Sheet
The Fundamentals of Human Abuse Potential (HAP) Studies: A 7-Point Checklist
Improving the science of abuse assessment before a drug is marketed is a unified goal for the FDA and pharmaceutical industry. It is the hope that…
Capability
Strategic Solutions Division Biometric Services
PRA Health Sciences is a global CRO with nearly 17,000 employees around the world. We support biotech and small to large pharmaceutical companies…
White Paper
Local Representation: What Clinical Trial Sponsors Need to Know
In this white paper, best practices are described as well as required Sponsor/Local Representative agreement areas. It is important that major…